BioMerieux Q4 Revenues Up 7 Percent, Aided by Strong FilmArray Sales

Jan 19, 2017

|

NEW YORK (GenomeWeb) – BioMérieux today reported that its fourth quarter revenues rose 7 percent year over year, driven in large part by an uptick in revenues for its FilmArray molecular diagnostic products.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

BioMerieux Q4 Revenues Up 7 Percent, Aided by Strong FilmArray Sales

To read the full story....

Breaking News

BTIG Initiates Coverage of Progenity With Buy Rating

FDA Approves Avioq's Supplemental HIV Test

FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

In Brief This Week: Oxford Immunotec, Eurofins, WHO, and More

Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences

Genetron Health Licenses ImmuQuad Technology for Blood Cancer Testing

Featured White Papers

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

What's Popular?

COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

BTIG Initiates Coverage of Progenity With Buy Rating

Danaher Q3 Revenues Up 35 Percent

Thermo Fisher Scientific Continues to See Strong Demand for Pandemic-Related Products and Services

Sponsorships